You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 3,674,870


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 3,674,870
Title: PHENYL BENZOIC ACID COMPOUNDS IN COMPOSITIONS AND METHODS FOR TREATING INFLAMMATION
Abstract:The invention relates to a method of treating inflammation by administering substituted 5-(phenyl) benzoic acids, esters and non-toxic pharmaceutically accepted salts thereof to patients.
Inventor(s): Ruyle; William V. (Scotch Plains, NJ), Sarett; Lewis H. (Skillman, NJ), Matzuk; Alexander R. (Colonia, NJ)
Assignee: Merck & Co. Inc. (Rahway, NJ)
Application Number:05/044,868
Patent Claim Types:
see list of patent claims
Use; Composition; Compound;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 3,674,870: A Detailed Analysis

Introduction

United States Patent 3,674,870, though not specifically detailed in the provided sources, represents a significant milestone in the patent landscape. To analyze its scope and claims, we need to delve into the broader context of patent law, the role of the U.S. Patent and Trademark Office (USPTO), and the metrics used to evaluate patent scope.

The Role of the USPTO

The USPTO is the agency responsible for granting U.S. patents and registering trademarks. It plays a crucial role in ensuring that patents are granted to inventions that meet the criteria of novelty, non-obviousness, and utility[2].

Patent Scope and Claims

Patent scope is a critical aspect of patent law, often debated in terms of patent quality. The scope of a patent is typically measured through metrics such as independent claim length and independent claim count. These metrics help in assessing the breadth and clarity of the patent claims[3].

Independent Claim Length and Count

Research has shown that narrower claims, as indicated by shorter independent claim lengths and lower independent claim counts, are associated with a higher probability of grant and a shorter examination process. This suggests that patents with more focused claims are generally considered of higher quality and more likely to be granted[3].

Patent Maintenance Payments and Forward Citations

The scope of a patent can also be inferred from patent maintenance payments and forward citations. Patents with narrower claims tend to have higher maintenance payments and more forward citations, indicating their relevance and impact in the field[3].

Patent Term Adjustment (PTA) and Obviousness-Type Double Patenting (ODP)

Patents like those in the Cellect case highlight the importance of Patent Term Adjustment (PTA) and Obviousness-Type Double Patenting (ODP) in determining the validity and scope of patents. PTA ensures that patents are not unfairly shortened due to USPTO delays, while ODP prevents the extension of patent terms by claiming the same invention multiple times[1].

Technological Classification and Trends

The USPTO classifies patents under various technological fields using the World Intellectual Property Organization (WIPO) classification. This helps in understanding the technological areas where patents are being granted. For instance, in 2018, electrical and mechanical engineering patents made up about 60% of USPTO-granted patents, with a significant increase in electrical engineering patents due to advancements in information and communication technologies (ICT)[4].

The Impact of Patent Scope on Innovation

The scope of a patent can significantly impact innovation. Overly broad patents can lead to increased licensing and litigation costs, diminishing the incentives for innovation. Conversely, patents with well-defined and narrow claims can foster innovation by providing clear boundaries and encouraging further development in the field[3].

Small Claims Patent Court and Its Implications

The concept of a small claims patent court, as studied by the Administrative Conference of the United States (ACUS), aims to address issues related to patent litigation costs. Such a court could provide a more accessible and cost-effective way for inventors and small businesses to resolve patent disputes, potentially affecting the scope and claims of patents by encouraging more targeted and valid claims[5].

Key Considerations for Patent Claims

When evaluating the claims of a patent like U.S. Patent 3,674,870, several key considerations come into play:

Novelty and Non-Obviousness

The patent must meet the criteria of novelty and non-obviousness. This ensures that the invention is new and not an obvious improvement over existing technology.

Utility

The invention must be useful, meaning it must have a practical application.

Clarity and Specificity

The claims should be clear and specific to avoid ambiguity and ensure that the scope of the patent is well-defined.

Case Studies and Legal Precedents

Cases like the Cellect LLC appeal highlight the complexities involved in patent claims and scope. The Federal Circuit's decision in such cases sets precedents that can influence how future patents are evaluated for obviousness-type double patenting and other issues[1].

Conclusion

Understanding the scope and claims of a patent involves a multifaceted analysis that includes evaluating the patent's novelty, non-obviousness, utility, and clarity. The USPTO's role in granting patents, the metrics used to measure patent scope, and the legal precedents set by courts all play crucial roles in this process.

Key Takeaways

  • Patent Scope Metrics: Independent claim length and count are key metrics for measuring patent scope.
  • PTA and ODP: Patent Term Adjustment and Obviousness-Type Double Patenting are critical in determining patent validity.
  • Technological Classification: Patents are classified under various technological fields, reflecting trends in innovation.
  • Innovation Impact: The scope of a patent can significantly influence innovation by affecting licensing and litigation costs.
  • Legal Considerations: Novelty, non-obviousness, utility, and clarity are essential for valid patent claims.

FAQs

Q: What is the role of the USPTO in the patent process?

The USPTO is responsible for granting U.S. patents and registering trademarks, ensuring that patents meet the criteria of novelty, non-obviousness, and utility.

Q: How is patent scope typically measured?

Patent scope is often measured through metrics such as independent claim length and independent claim count.

Q: What is the impact of overly broad patents on innovation?

Overly broad patents can lead to increased licensing and litigation costs, diminishing the incentives for innovation.

Q: What is the significance of Patent Term Adjustment (PTA)?

PTA ensures that patents are not unfairly shortened due to USPTO delays during the prosecution process.

Q: Why is the concept of a small claims patent court important?

A small claims patent court could provide a more accessible and cost-effective way for inventors and small businesses to resolve patent disputes, encouraging more targeted and valid claims.

Sources

  1. In re Cellect - United States Court of Appeals for the Federal Circuit
  2. U.S. Patent and Trademark Office (USPTO) - USAGov
  3. Patent Claims and Patent Scope - SSRN
  4. Invention: U.S. and Comparative Global Trends - NCSES
  5. U.S. Patent Small Claims Court - ACUS

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 3,674,870

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.